Report: Elon Musk’s drug use ramped up during the 2024 presidential campaign

A New York Times report alleges Elon Musk's drug use, including ketamine and Adderall, escalated during the 2024 election cycle, raising concerns among Tesla and SpaceX board members, particularly given SpaceX's status as a government contractor requiring a drug-free workplace. The report suggests Musk received advanced notice of drug tests and links his increased drug use to erratic behavior and a shift towards right-wing politics amid personal family issues. Musk has announced he is ending his political involvement to focus on his businesses and is scheduled to appear with President Trump at a press conference Friday.

Analysis

A New York Times report alleging a significant escalation in Elon Musk's drug consumption, including ketamine and Adderall, during the 2024 presidential campaign presents material concerns for the companies he leads, notably Tesla (TSLA) and SpaceX. The Times reports his drug consumption went beyond recreational use, with sources indicating his ketamine use affected his bladder and that he carried a medication box with 20 pills, including Adderall. These allegations, coupled with reports of him receiving advanced notice of drug tests, raise serious questions about corporate governance and compliance, particularly for SpaceX, a large government contractor required to maintain a drug-free workplace, directly impacting the 'Management & Governance' theme. While the article states it is not clear if his erratic behavior—such as insulting cabinet members, doing the Nazi salute, and jumbled speech during earnings calls—was directly correlated to his reported drug-taking, the potential linkage could further erode investor confidence and damage company reputation. The report details this period coincided with Musk's increasing embrace of right-wing politics and family troubles. Musk's recent announcement that he is ending his political involvement to focus on his businesses, alongside a scheduled joint press conference with President Trump, will be critical events for investors to monitor. The 'strongly negative' sentiment score of -0.7, a 'pessimistic' tone, and a high market impact score of 0.7, with Tesla's specific sentiment at -0.6, underscore the potential for heightened volatility and significant investor scrutiny concerning leadership stability and operational risks at his companies.

Key Decisions for Investors

• Investors in Tesla (TSLA) should closely monitor for any board-level responses or independent investigations into these allegations concerning CEO conduct and corporate governance practices.
• Given the 'strongly negative' sentiment (-0.6 for TSLA) and high market impact score (0.7), investors should prepare for potential increased volatility in TSLA stock and assess the impact of these leadership concerns on the company's brand and operational stability.
• Closely observe Elon Musk's upcoming public appearances, including the joint press conference with President Trump, and his communications regarding his commitment to focus on his businesses, as these may provide further insight into his conduct and leadership stability.
• Assess the risk that ongoing scrutiny of Musk's behavior and the governance challenges at his companies, including potential issues at SpaceX related to its government contractor status, could distract leadership and impact strategic execution at Tesla.